Showing 1-10 of 1828 results for "".
- Mathias Basner, MD, PhD, MSchttps://practicalneurology.com/profiles/mathias-basner-md-phd-msc/7ZBpeR/
Young-Onset ALS: Diagnosis and Research
https://practicalneurology.com/diseases-diagnoses/neuromuscular/young-onset-als-diagnosis-and-research/30098/In this episode, Gwen Petersen discusses her long journey to receiving an ALS diagnosis at age 32, her contributions to a Cytokinetics book project, and the importance of clinical trial participation. We are also joined by Merit Cudkowicz, MD, MSc, Head of the Department of Neurology, Chief of NeuroMonoclonal Antibody Studies
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/monoclonal-antibody-studies/30233/An Interview with Rachelle S. Doody, MD, PhDELEVATE (Qulipta for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments; NCT04740827)
https://practicalneurology.com/programs/practical-neurology/elevate-qulipta-for-prophylaxis-of-migraine-in-participants-who-failed-previous-oral-prophylactic-treatments-nct04740827/31255/Patricia Pozo-Rosich, MD, PhD, Headache Specialist from the Vall d’Hebron University Hospital in Barcelona, Spain, provides an overview of the ELEVATE clinical trial.Seeking Breakthroughs: The Physician Perspective
https://practicalneurology.com/columns/practice-management/the-physician-perspective/30193/A roundtable discussion with Claudia A. Chiriboga, MD, MPH; Jeffrey L. Cummings, MD, ScD; and Nir Lipsman, MD, PhDMedication-Overuse Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/medication-overuse-headache/30281/Questions and answers from Nina Tsakadze, MD, PhD; Natasha Antonovich; PharmD; and Fabian Rossi, MDSeeking Breakthroughs: The Startup Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin TherapeuticsSeeking Breakthroughs: The Industry Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-industry-perspective/30192/A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCBFactors Influencing the Selection of CSF Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-csf-tests-for-alzheimer-disease/35726/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of cerebrospinal fluid tests for Alzheimer disease.New Guidelines for the Assessment of Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/new-guidelines-for-the-assessment-of-traumatic-brain-injury/35727/Beth McQuiston, MD, RD, Medical Director, Abbott, Abbott Park, IL, and David Okonkwo, MD, PhD, Professor of Neurological Surgery, the University of Pittsburgh, Pittsburg, PA, describe some of the important updates to guidelines for the assessment of traumatic brain injury, including biomarker testin
- Prev
- Next